BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Janic B, Arbab AS. Cord blood endothelial progenitor cells as therapeutic and imaging probes. Imaging Med 2012;4:477-90. [PMID: 23227114 DOI: 10.2217/iim.12.35] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Oliveira CS, Carreira M, Correia CR, Mano JF. The Therapeutic Potential of Hematopoietic Stem Cells in Bone Regeneration. Tissue Eng Part B Rev 2021. [PMID: 33683146 DOI: 10.1089/ten.TEB.2021.0019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Armanetti P, Chillà A, Margheri F, Biagioni A, Menichetti L, Margheri G, Ratto F, Centi S, Bianchini F, Severi M, Traversi R, Bani D, Lulli M, Del Rosso T, Mocali A, Rovida E, Del Rosso M, Fibbi G, Laurenzana A. Enhanced Antitumoral Activity and Photoacoustic Imaging Properties of AuNP-Enriched Endothelial Colony Forming Cells on Melanoma. Adv Sci (Weinh) 2021;8:2001175. [PMID: 33643785 DOI: 10.1002/advs.202001175] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
3 Chillà A, Margheri F, Biagioni A, Del Rosso T, Fibbi G, Del Rosso M, Laurenzana A. Cell-Mediated Release of Nanoparticles as a Preferential Option for Future Treatment of Melanoma. Cancers (Basel) 2020;12:E1771. [PMID: 32630815 DOI: 10.3390/cancers12071771] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Alatyyat SM, Alasmari HM, Aleid OA, Abdel-Maksoud MS, Elsherbiny N. Umbilical cord stem cells: Background, processing and applications. Tissue Cell 2020;65:101351. [PMID: 32746993 DOI: 10.1016/j.tice.2020.101351] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
5 Loisel F, Provost B, Guihaire J, Boulate D, Arouche N, Amsallem M, Arthur-Ataam J, Decante B, Dorfmüller P, Fadel E, Uzan G, Mercier O. Autologous endothelial progenitor cell therapy improves right ventricular function in a model of chronic thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg 2019;157:655-666.e7. [PMID: 30669226 DOI: 10.1016/j.jtcvs.2018.08.083] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
6 Han SS, Shim HE, Park SJ, Kim BC, Lee DE, Chung HM, Moon SH, Kang SW. Safety and Optimization of Metabolic Labeling of Endothelial Progenitor Cells for Tracking. Sci Rep 2018;8:13212. [PMID: 30181604 DOI: 10.1038/s41598-018-31594-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
7 Laurenzana A, Margheri F, Chillà A, Biagioni A, Margheri G, Calorini L, Fibbi G, Del Rosso M. Endothelial Progenitor Cells as Shuttle of Anticancer Agents. Hum Gene Ther 2016;27:784-91. [PMID: 27502560 DOI: 10.1089/hum.2016.066] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
8 Yuan JJ, Yang J, Sun SL, Zhang R, Xu YM. Endothelial Progenitor Cells' Classification and Application in Neurological Diseases. Tissue Eng Regen Med 2017;14:327-32. [PMID: 30603489 DOI: 10.1007/s13770-017-0043-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
9 Angara K, Rashid MH, Shankar A, Ara R, Iskander A, Borin TF, Jain M, Achyut BR, Arbab AS. Vascular mimicry in glioblastoma following anti-angiogenic and anti-20-HETE therapies. Histol Histopathol 2017;32:917-28. [PMID: 27990624 DOI: 10.14670/HH-11-856] [Cited by in F6Publishing: 25] [Reference Citation Analysis]
10 Shaaban S, Alsulami M, Arbab SA, Ara R, Shankar A, Iskander A, Angara K, Jain M, Bagher-Ebadian H, Achyut BR, Arbab AS. Targeting Bone Marrow to Potentiate the Anti-Tumor Effect of Tyrosine Kinase Inhibitor in Preclinical Rat Model of Human Glioblastoma. Int J Cancer Res 2016;12:69-81. [PMID: 27429653 DOI: 10.3923/ijcr.2016.69.81] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
11 Shankar A, Borin TF, Iskander A, Varma NR, Achyut BR, Jain M, Mikkelsen T, Guo AM, Chwang WB, Ewing JR, Bagher-Ebadian H, Arbab AS. Combination of vatalanib and a 20-HETE synthesis inhibitor results in decreased tumor growth in an animal model of human glioma. Onco Targets Ther 2016;9:1205-19. [PMID: 27022280 DOI: 10.2147/OTT.S93790] [Cited by in Crossref: 2] [Cited by in F6Publishing: 14] [Article Influence: 0.3] [Reference Citation Analysis]
12 Il'yasova D, Kloc N, Kinev A. Cord Blood Cells for Developmental Toxicology and Environmental Health. Front Public Health 2015;3:265. [PMID: 26697419 DOI: 10.3389/fpubh.2015.00265] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
13 Achyut BR, Varma NR, Arbab AS. Application of Umbilical Cord Blood Derived Stem Cells in Diseases of the Nervous System. J Stem Cell Res Ther 2014;4:1000202. [PMID: 25599002 DOI: 10.4172/2157-7633.1000202] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
14 Ali MM, Kumar S, Shankar A, Varma NR, Iskander AS, Janic B, Chwang WB, Jain R, Babajeni-Feremi A, Borin TF, Bagher-Ebadian H, Brown SL, Ewing JR, Arbab AS. Effects of tyrosine kinase inhibitors and CXCR4 antagonist on tumor growth and angiogenesis in rat glioma model: MRI and protein analysis study. Transl Oncol 2013;6:660-9. [PMID: 24466368 DOI: 10.1593/tlo.13559] [Cited by in Crossref: 26] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]